for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Freeline Therapeutics Holdings PLC (ADR)

FRLN.OQ

Latest Trade

3.95USD

Change

0.00(0.00%)

Volume

100

Today's Range

--

 - 

--

52 Week Range

2.98

 - 

18.88

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
3.95
Open
0.00
Volume
100
3M AVG Volume
9.68
Today's High
--
Today's Low
--
52 Week High
18.88
52 Week Low
2.98
Shares Out (MIL)
35.80
Market Cap (MIL)
141.42
Forward P/E
-1.07
Dividend (Yield %)
--

Next Event

Freeline Therapeutics Holdings PLC Annual Shareholders Meeting

Latest Developments

More

Freeline Therapeutics Holdings Files For Mixed Shelf Of Up To $250 Million

Freeline Therapeutics Holdings Appoints Michael Parini As CEO

Freeline Therapeutics Holdings Posts Quarterly Loss Per Share Of $0.98

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Freeline Therapeutics Holdings PLC (ADR)

Freeline Therapeutics Holdings plc is a clinical-stage systemic adeno-associated viruses (AAV)-based gene therapy company. The Company focuses to deliver one-time gene therapy treatments that provide functional cures through permanently sustained physiological protein levels, leveraging the expression enabled by its gene therapy platform. Its gene therapy product candidates target the liver in order to cause the production of proteins that are released in the bloodstream at levels sufficient to have a therapeutic benefit. The Company’s platform includes capsid and promoter, research tools and capabilities, and manufacturing. It manufactures the product candidates using its split-plasmid system running in the iCELLis adherent mammalian cell production system. Its product candidates include FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease, FLT201 for the treatment of Gaucher disease and FLT210 for the treatment of hemophilia A.

Industry

Biotechnology & Drugs

Contact Info

Stevenage Bioscience Catalyst

Gunnels Wood Road, Stevenage

SG1 2FX

United Kingdom

+44.1438.906870

https://www.freeline.life/

Key Stats

2.00 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.0K

2021(E)

0.0K
EPS (USD)

2020

-6.370

2021(E)

-3.695
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
0.76
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up